Other families of tyrosine kinase receptors that are HCC drug targets include platelet-derived growth factor receptors (PDGFRs), and fibroblast growth factor receptors (FGFRs) [43–46]. The gene discussed is NTRK1; the disease is hepatocellular carcinoma.